Positive Topline Results for Novartis' Leqvio® in Lowering LDL-C in Low-to-Moderate ASCVD Risk Patients
Aug 28, 2024
Monotherapy Invest Information
Xilio Therapeutics Commences Phase 1 Trial for XTX101 in Combination Therapy for MSS CRC
Dec 7, 2023